Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €1.32 EUR
Change Today -0.048 / -3.51%
Volume 900.0
As of 6:09 AM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

alibaba health information t (TWY) Snapshot

Open
€1.32
Previous Close
€1.37
Day High
€1.33
Day Low
€1.32
52 Week High
04/22/15 - €1.72
52 Week Low
10/30/14 - €0.47
Market Cap
10.8B
Average Volume 10 Days
9.1K
EPS TTM
--
Shares Outstanding
8.2B
EX-Date
03/26/03
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ALIBABA HEALTH INFORMATION T (TWY)

Related News

No related news articles were found.

alibaba health information t (TWY) Related Businessweek News

No Related Businessweek News Found

alibaba health information t (TWY) Details

Alibaba Health Information Technology Limited, an investment holding company, provides integrated information and content services in the People's Republic of China. It operates through Product Identification, Authentication, and Tracking System (PIATS) Business; and System Integration and Software Development segments. The company offers product tracking, recall, and enforcement information services to relevant authorities through the operation of PIATS; product tracking and logistics information services to manufacturers; and services to consumers for verifying product information and origins. Its PIATS is used for various products, such as drugs, food and beverage, cosmetics, and agricultural resources. The company also provides telecommunications/information value-added services (VAS) comprising SMS, IVRS, and other telecom services; call center outsourcing service for telecom operators, financial institutions, and e-commerce companies; and other telecommunication/information VAS include IP phone service and business SMS services, as well as offers governmental, commercial, and entertainment information through its SMS and IVRS services. The company was formerly known as CITIC 21CN Company Limited and changed its name to Alibaba Health Information Technology Limited in September 2014. Alibaba Health Information Technology Limited is based in Central, Hong Kong.

186 Employees
Last Reported Date: 12/22/14

alibaba health information t (TWY) Top Compensated Officers

Executive Vice Chairman
Total Annual Compensation: $1.3M
Compensation as of Fiscal Year 2014.

alibaba health information t (TWY) Key Developments

Alibaba Health Information Technology Limited Announces Management Changes

The board of directors of Alibaba Health Information Technology Limited announced that Dr. Wang Jian has resigned as chairman of the Board, executive director and chief executive officer of the company with effect from April 17, 2015, and that Mr. Chia Pun Kok has tendered his resignation as a non-executive director of the company with effect from April 17, 2015. Each of the outgoing directors has confirmed that there are no disagreements with the Board, nor are there any matters in relation to his resignation that need to be brought to the attention of the shareholders of the company (the Shareholders). The Board also announced the appointment of a new non-executive director and chairman of the Board, and a new executive director and chief executive officer, as follows: Mr. Wu Yongming has been appointed as a non-executive director of the company and chairman of the Board with effect from April 17, 2015; and Mr. Wang Lei has been appointed as an executive director and chief executive officer of the company with effect from April 17, 2015. Mr. WU Yongming, aged 40, is currently a senior vice president of Alibaba Group. Prior to his current position, Mr. Wu had been responsible for various major businesses within Alibaba Group, including Alibaba Groups search business, advertising business and mobile business. Mr. Wu is also currently serving as special assistant to the chairman of the board of directors of Alibaba Group Holding Limited. Mr. WANG Lei, aged 35, was, prior to his current position, the general manager of Alibaba Groups Taobao Diandian business from September 2013. Mr. Wang has held various positions within Alibaba Group since he joined Alibaba Group in 2003, including customer relationship management product manager and Alibaba call center project manager from September 2003 to December 2005, P4P project manager of Yahoo! China from January 2006 to May 2007, senior manager of Alimama product and operations department from June 2007 to December 2008, B2B advertising product and operations department director from January 2009 to May 2011, senior director of B2B advertising service department and commercial product department from June 2011 to July 2012 and O2O workshop senior director of Alibaba Groups mobile Internet business department from August 2012 to August 2013. As Dr. Wang Jian has resigned as chairman of the Board, executive director and chairman of the nomination committee (with effect from April 17, 2015) of the company, the Board announced that Mr. Wu Yongming has been appointed as chairman of the nomination committee with effect from April 17, 2015. As Dr. Wang Jian has resigned as executive director of the company (with effect from April 17, 2015), he will no longer act as the company's authorized representative and Mr. Wang Lei will instead be appointed as the company's authorized representative with effect from April 17, 2015.

Alibaba Health Information Technology Limited(SEHK:241) added to Hang Seng Composite Index

Alibaba Health Information Technology Limited has been added to Hang Seng Composite Index.

China Jo-Jo Drugstore Joins Alibaba Health's E-Prescription Platform in Anticipation of Online Prescription Drugs Sales in China

China Jo-Jo Drugstores Inc. announced that it has entered into a service agreement with Alibaba Health Information Technology Ltd. to utilize the electronic prescription platform in preparing for the upcoming authorization from the China Food and Drug Administration (CFDA) on the online sales of prescription drugs in China. Through Alibaba Health's recently launched mobile app, Alijk, patients are able to upload and send photocopies of doctor's prescriptions to nearby pharmacies so as to check the availability of medicines, compare the prices and eventually make the payments. Those qualified pharmacies partnering with Alibaba Health, such as China Jo-Jo, can then fill the orders via in-store purchase or home delivery service. By combining Alibaba Health's online platform with the Company's offline pharmacy expertise, China Jo-Jo believes this innovative business model will greatly benefit its customers, and open up new growth opportunities.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TWY:GR €1.32 EUR -0.048

TWY Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Pakistan Telecommunication Co Ltd 20.60 PKR +0.12
Qihoo 360 Technology Co Ltd $54.96 USD +1.37
SINA Corp/China $42.63 USD +0.52
Sohu.com Inc $66.13 USD -0.05
Youku Tudou Inc $26.97 USD +3.95
View Industry Companies
 

Industry Analysis

TWY

Industry Average

Valuation TWY Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1,188.9x
Price/Book 55.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1,283.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALIBABA HEALTH INFORMATION T, please visit www.citic21cn.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.